ABBOTT PARK, Ill., Aug. 6, 2001 – Abbott Laboratories announced today it has received U.S. Food and Drug Administration (FDA) approval of a new seven-day indication for Biaxin(R) XL (clarithromycin ...
Add Yahoo as a preferred source to see more of our stories on Google. The Food and Drug Administration (FDA) has issued a warning advising prescribers to practice caution before prescribing the common ...
Trial CL-05 Results Showed Cethromycin had 94.0% Clinical Cure Rate Compared to 93.8% Clinical Cure Rate for Biaxin(R), a Current Standard of Care Treatment Trial CL-05 and Trial CL-06 to Form the ...
WASHINGTON, Jan 5 (Reuters) - A U.S. appeals court on Friday upheld a lower court ruling blocking Andrx Pharmaceuticals from selling a generic version of Abbott Laboratories Inc.'s extended-release ...
Biaxin contains an active ingredient called Clarithromycin. It belongs to the class of antibiotics called macrolides. Biaxin Clarithromycin is a semisynthetic macrolide antibiotic. It acts by ...
Generic drugmaker Teva Pharmaceutical Industries has halted sales of its new antibiotic product clarithromycin in the USA after another legal salvo from the drug’s originator Abbott Laboratories.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results